Toxicity, biodegradation and elimination of polyanhydrides

Advanced Drug Delivery Reviews

Volumn 54, Issue 7, 2002, Pages 933-961

  Katti, D S ^a   Lakshmi, S ^a   Langer, R ^b   Laurencin, C T ^a,c  

^a Drexel University   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Biocompatibility; Biodegradation; Poly(anhydride co imides); Polyanhydrides; Toxicity

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; COPOLYMERIZATION; HYDROLYSIS; MONOMERS; TEXTILE INDUSTRY; TOXICITY;

BIOMEDICAL APPLICATIONS;

ORGANIC POLYMERS;

3 CARBOXY 2,2,5,5 TETRAMETHYLPYRROLLIDINE 1 OXYL; 8 AZAGUANINE; ACID; ACID ANHYDRIDE; ADIPIC ACID; ANTIINFECTIVE AGENT; AZELAIC ACID; CARBROMAL; CARMUSTINE; CORTISONE; DEXAMETHASONE; DODECANE; DODECANEDICARBOXYLIC ACID; DODECANEDIOCIC ACID; GELFOAM; HEPARIN; OXIDIZED REGENERATED CELLULOSE; PIMELIC ACID; POLY(ANHYDRIDE CO IMIDIS); POLY(CARBOXYPHENOXYPROPANE SEBACIC ACID); POLYANHYDRIDE; POLYGLACTIN; POLYMER; POLY[TRIMELLITYIMIDOGLYCYINE CO 1,6 BIS(1,4 CARBOXYPHENOXY)HEXANE]; SEBACIC ACID; SUBERIC ACID; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; BIODEGRADATION; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG METABOLISM; DRUG RELEASE; DRUG SYNTHESIS; EDEMA; GLIOSIS; HUMAN; HYDROLYSIS; NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; RESTLESSNESS; REVIEW;

EID: 0037120666     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00052-2     Document Type: Article

References (54)

1. Ratner B.D., Hoffman A.S., Schoen F.J., Lemons J.E., Biomaterials Science. An Introduction to Materials in Medicine. 1996;Academic Press, San Diego, CA.
2. Tamada J.A., Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc. Natl. Acad. Sci. USA. 90:1993;552-556.
3. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 17:1996;103-114.
4. Gopferich A., Langer R. Predicting drug release from cylindric polyanhydride matrix discs. Eur. J. Pharmacol. Biopharmacol. 41:1995;81-87.
5. Tamada J., Langer R. The development of polyanhydrides for drug delivery applications. J. Biomater. Sci.: Polymer Edn. 3:1992;315-353.
6. Heller J., Himmelstein K.J. Biodegradable poly(orthoesters) as drug delivery forms. Borchardt R.T., Arnold J., Stella V.J., Directed Drug Delivery. 1985;171-188 Humana, Clifton, NJ.
7. Rosen H.B., Chang J., Wnek G.E., Linhardt R.J., Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials. 4:1983;131-133.
8. Domb A.J., Amselem S., Langer R., Maniar M. Polyanhydrides as carriers of drugs. Shalaby S.W., Biomedical Polymers. Designed to Degrade Systems. 1994;69-96 Hanser, New York.
9. Leong K.W., Brott B.C., Langer R. Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation and release characteristics. J. Biomed. Mater. Res. 19:1985;941-955.
10. Domb A.J., Nudelman R. In vivo and in vitro elimination of aliphatic polyanhydrides. Biomaterials. 16:1995;319-323.
11. Mathiowitz E., Kline D., Langer R. Morphology of polyanhydride microsphere delivery systems. J. Scan. Microsc. 4:1990;329-340.
12. Shieh L., Tamada J., Chen I., Pang J., Domb A.J., Langer R. Erosion of a new family of degradable polyanhydrides. J. Biomed. Mater. Res. 28:1994;1465-1475.
13. Akbari H., D'Emanuele A., Attwood D. Effect of geometry on the erosion characteristics of polyanhydride matrices. Int. J. Pharm. 160:1998;83-89.
14. Park E., Maniar M., Shah J. Effects of model compounds with varying physiochemical properties on erosion of polyanhydride devices. J. Control. Release. 40:1996;111-121.
15. Seidel J.O., Uhrich K.E., Laurencin C.T., Langer R. Erosion of poly(anhydride-co-imides): a preliminary mechanistic study. J. Appl. Polym. Sci. 62:1996;1277-1283.
16. Kost J., Leong K.W., Langer R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl. Acad. Sci. USA. 86:1989;7663-7666.
17. ® wafer initial molecular weight on the erosion of wafer and release of BCNU. J. Control. Release. 42:1996;83-92.
18. ® during in vitro and in vivo erosion using scanning electron microscopy. Pharm. Res. 13:1996;683-691.
19. Mader K., Bacic G., Domb A., Elmalak O., Langer R., Swartz H.M. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J. Pharm. Sci. 86:1997;126-134.
20. Mader K., Cremmilleux Y., Domb A.J., Dunn J.F., Swartz H.M. In vitro/in vivo comparison of drug release and polymer erosion from biodegradable P(FAD-SA) polyanhydrides - a noninvasive approach by the combined use of electron paramagnetic resonance spectroscopy and nuclear magnetic resonance imaging. Pharm. Res. 14:1997;820-826.
21. Uhrich K.E., Ibim S.E.M., Larrier D.R., Langer R., Laurencin C.T. Chemical changes during in vivo degradation of poly(anhydride-imide) matrices. Biomaterials. 19:1998;2045-2050.
22. Uhrich K.E., Thomas T., Laurencin C., Langer R. In vitro degradation characteristics of poly(anhydride-co-imides) containing trimellitylimidoglycine. J. Appl. Polym. Sci. 63:1997;1401-1412.
23. Uhrich K.E., Larrier D., Laurencin C., Langer R. In vitro degradation characteristics of poly(anhydride-imides) containing pyromellitylimidoalanine. J. Polym. Sci. Part A: Polym. Chem. 34:1996;1261-1269.
24. Brem H., Mahaley M.S., Vick N.A., Black K.L., Schold S.C., Eller T.W., Cozzens J.W., Kenealy J.N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 74:1991;441-446.
25. Wu M.P., Tamada J.A., Brem H., Langer R. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J. Biomed. Mater. Res. 28:1994;387-395.
26. Weiner I.M. Excretion of drugs by the kidney. Brodie B.B., Gillete J.R., Handbook of Experimental Pharmacology. Concepts in Biomedical Pharmacology. 1971;328-353 Springer, New York.
27. P.G. Killneberg, L.T. Webster, Conjugation by peptide bond formation, in: W.B. Jakoby (Ed.), Enzymatic Basis of Detoxification, Vol. 2, Academic Press, New York, NY, 1980, pp. 141-167.
28. Domb A.J., Rock M., Schwartz J., Perkin C., Yipchuck G., Broxup B., Villemure J.G. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain. Biomaterials. 15:1994;681-688.
29. Domb A.J., Roack M., Perkin C., Yipchuck G., Broxup B., Villemure J.G. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials. 16:1995;1069-1072.
30. J. Black (Ed.), in: Biological Performance of Materials, Fundamentals of Biocompatibility, Marcel Dekker, New York, 1999.
31. Leong K.W., D'Amore P., Marletta M., Langer R. Bioerodible polyanhydrides as drug carrier matrices. II. Biocompatibility and chemical reactivity. J. Biomed. Mater. Res. 20:1986;51-64.
32. Jaffe E.A., Nachman R.L., Becker C.G., Minck C.R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:1973;2745-2756.
33. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J. Cell Biol. 50:1971;172-186.
34. Attawia M.A., Uhrich K.E., Botchwey E., Fan M., Langer R., Laurencin C.T. Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. J. Biomed. Mater. Res. 29:1995;1233-1240.
35. Laurencin C.T., Morris C., Pierre-Jacques H., Schwartz E. Osteoblast culture on bioerodible polymers: studies of initial cell adhesion and spread. Polym. Adv. Tech. 3:1992;359-364.
36. Attawia M.A., Uhrich K.E., Botchwey E., Langer R., Laurencin C.T. In vitro bone biocompatibility of poly(anhydride-co-imides) containing pyromellitylimidoalanine. J. Orthop. Res. 14:1996;445-454.
37. Attawia M.A., Herbert K.M., Uhrich K.E., Langer R., Laurencin C.T. Proliferation, morphology and protein expression by osteoblasts cultured on poly(anhydride-co-imides). J. Biomed. Mater. Res. (Appl. Biomater.). 48:1999;322-327.
38. Skopek T.R., Liber H.L., Krolewski J.J., Thilly W.G. Quantitative forward mutation assay in salmonella typhimurium using 8-azaguanine resistance as a genetic marker. Proc. Natl. Acad. Sci. USA. 75:1978;410-414.
39. Braun A.G., Buckner C.A., Emerson D.J., Nichinson B.B. Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents. Proc. Natl. Acad. Sci. USA. 79:1982;2056-2060.
40. Brem H., Kader A., Epstein J.I., Tamargo R.J., Domb A., Langer R., Leong K.W. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. Sel. Cancer Ther. 5:1989;55-65.
41. Domb A.J. Synthesis and characterization of biodegradable aromatic anhydride copolymers. Macromolecules. 25:1992;12-17.
42. Domb A.J., Maniar M. Absorbable biopolymers derived from dimers fatty acids. J. Polym. Sci. Part A: Polym. Chem. 31:1993;1275-1285.
43. Ibim S.M., Uhrich K.E., Bronson R., El-Amin S.F., Langer R., Laurencin C.T. Poly(anhydride-co-imides): in vivo biocompatibility in a rat model. Biomaterials. 19:1998;941-951.
44. Ibim S.E.M., Uhrich K.E., Attawia M., Shastri V.R., El-Amin S.F., Bronson R., Langer R., Laurencin C.T. Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. J. Biomed. Mater. Res. (Appl. Biomater.). 43:1998;374-379.
45. Hanes J., Chiba M., Langer R. Degradation of porous poly(anhydride-co-imide) microspheres and implications of controlled macromolecule delivery. Biomaterials. 19:1998;163-172.
46. Laurencin C.T., Domb A., Morris C., Brown V., Chasin M., McConnell R., Lange N., Langer R. Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J. Biomed. Mater. Res. 24:1990;1463-1481.
47. Teomim D., Nyska A., Domb A.J. Ricinoleic acid-based biopolymers. J. Biomed. Mater. Res. 45:1999;258-267.
48. Pedley B., Meachim G., Williams D.F. Tumour induction by implant materials. Williams D.F., Fundamental Aspects of Biocompatibility. Vol. II:1981;175-202 CRC Press, Boca Raton, FL.
49. Brem H. Controlled-release polymer systems for drug delivery to the brain. Polymer Preprints. 31:1990;229.
50. Reinhard C.S., Radpmsky M., Saltzman M., Brem H. Polymeric controlled release of dexamethasone in normal rat brain. J. Control. Release. 16:1991;331-340.
51. Tamargo R.J., Leong K.W., Brem H. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J. Neurooncol. 9:1990;131-138.
52. Tamargo R.J., Epstein J.I., Reinhard C.S., Chasin M., Brem H. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J. Biomed. Mater. Res. 23:1989;253-266.
53. Arand A.G., Sawaya R. Intraoperative chemical hemostasis in neurosurgery. Neurosurgery. 18:1986;223-233.
54. Brem H., Domb A., Lenartz D., Dureza C., Olivi A., Epstein J.I. Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid. J. Control. Release. 19:1992;325-330.